Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems. / Hook, S.; Rades, T.

Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Springer New York, 2013. p. 233-261.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Hook, S & Rades, T 2013, Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems. in Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Springer New York, pp. 233-261. https://doi.org/10.1007/978-1-4614-5070-2_12

APA

Hook, S., & Rades, T. (2013). Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems. In Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines (pp. 233-261). Springer New York. https://doi.org/10.1007/978-1-4614-5070-2_12

Vancouver

Hook S, Rades T. Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems. In Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Springer New York. 2013. p. 233-261 https://doi.org/10.1007/978-1-4614-5070-2_12

Author

Hook, S. ; Rades, T. / Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Springer New York, 2013. pp. 233-261

Bibtex

@inbook{0f74a6ed84634c8a9fe3c1913193dc72,
title = "Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems",
abstract = "Immune stimulating complexes (ISCOMs) belong to the group of particulate vaccine delivery systems. These particles have received considerable attention in the field of vaccine delivery systems, especially for subunit vaccines. ISCOMs have a spherical, open and cage-like structure and a particle size of around 40nm. They contain an adjuvant (Quil A or QS 21) and an antigen incorporated into or associated with their colloidal structure, making ISCOMs particulate antigen delivery systems which allow co-delivery of antigen and adjuvant. In this chapter we initially describe the components, microstructures and preparation methods of ISCOMs followed by their mechanism of immune stimulation and their use as vaccines.",
author = "S. Hook and T. Rades",
note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2013. All rights reserved.",
year = "2013",
month = jan,
day = "1",
doi = "10.1007/978-1-4614-5070-2_12",
language = "English",
isbn = "9781461450696",
pages = "233--261",
booktitle = "Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines",
publisher = "Springer New York",
address = "United States",

}

RIS

TY - CHAP

T1 - Immune stimulating complexes (ISCOMs) and Quil-A containing particulate formulations as vaccine delivery systems

AU - Hook, S.

AU - Rades, T.

N1 - Publisher Copyright: © Springer Science+Business Media New York 2013. All rights reserved.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Immune stimulating complexes (ISCOMs) belong to the group of particulate vaccine delivery systems. These particles have received considerable attention in the field of vaccine delivery systems, especially for subunit vaccines. ISCOMs have a spherical, open and cage-like structure and a particle size of around 40nm. They contain an adjuvant (Quil A or QS 21) and an antigen incorporated into or associated with their colloidal structure, making ISCOMs particulate antigen delivery systems which allow co-delivery of antigen and adjuvant. In this chapter we initially describe the components, microstructures and preparation methods of ISCOMs followed by their mechanism of immune stimulation and their use as vaccines.

AB - Immune stimulating complexes (ISCOMs) belong to the group of particulate vaccine delivery systems. These particles have received considerable attention in the field of vaccine delivery systems, especially for subunit vaccines. ISCOMs have a spherical, open and cage-like structure and a particle size of around 40nm. They contain an adjuvant (Quil A or QS 21) and an antigen incorporated into or associated with their colloidal structure, making ISCOMs particulate antigen delivery systems which allow co-delivery of antigen and adjuvant. In this chapter we initially describe the components, microstructures and preparation methods of ISCOMs followed by their mechanism of immune stimulation and their use as vaccines.

UR - http://www.scopus.com/inward/record.url?scp=85028706534&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5070-2_12

DO - 10.1007/978-1-4614-5070-2_12

M3 - Book chapter

AN - SCOPUS:85028706534

SN - 9781461450696

SP - 233

EP - 261

BT - Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines

PB - Springer New York

ER -

ID: 299415622